Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
Filed with SSE · · 4 pages · Chinese
Release
Shanghai Shen Lian Biomedical Corporation on 6ix
Earlier from Shanghai Shen Lian Biomedical
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Attending the 2025 Semi-annual SSE STAR Market Innovative Drug Industry Collective Performance Briefing
- Announcement on Voluntary Disclosure of the Progress in Phase II Clinical Trial for Innovative Drug UB-221 of the Joint-Stock Company
- Special Report on Deposit and Use of Raised Funds in January-June 2025
- Announcement on Abnormal Fluctuations in Stock Trading
Later from Shanghai Shen Lian Biomedical
- Announcement on the Capital Increase and Share Expansion of an Associate Company to Introduce Strategic Investors, and on the Company’s Proposed Acquisition of Controlling Stake in the Associate Company and Signing of the Acquisition Framework Agreement and Related Party Transaction
- Announcement on Convening the Q3 2025 Performance Briefing
- Indicative Announcement on Equity Change of Shareholder with Over 5% Shares Reaching an Integral Multiple of 5%
- Indicative Announcement on Termination of Shareholders’ Acting-in-Concert Relationship and the Change Reaching an Integer Multiple of 5%
- Announcement on Renewing Engagement of Accounting Firm
Follow Shanghai Shen Lian Biomedical into a list and get an email when it puts out news.
Follow Shanghai Shen Lian Biomedical